Market Place
Sourcing Support
Memo Therapeutic Appoints Frits Alphen as Chief Development Officer
04 Nov 2024 //
GLOBENEWSWIRE
Memo Therapeutic Enrolls Patient in Potravitug Trial for BK Viremia
01 Nov 2024 //
GLOBENEWSWIRE
Kurma closes first $154M haul for biggest biotech fund yet
03 Oct 2024 //
FIERCE BIOTECH
Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
27 Aug 2024 //
GLOBENEWSWIRE
Memo Therapeutics AG appoints Paul Carter as Chairperson
08 Jul 2024 //
GLOBENEWSWIRE
Memo Therapeutics increases Series C financing to CHF 45 million
07 May 2024 //
GLOBENEWSWIRE
Memo Therapeutics AG Strengthens Management Team
05 Feb 2024 //
GLOBENEWSWIRE
Memo Therapeutics AG Appoints Erik van den Berg as Chief Executive Officer
16 Nov 2023 //
BUSINESSWIRE
Memo Therapeutics AG Raises CHF 25 Million Series C Financing
02 Nov 2023 //
BUSINESSWIRE
Memo enrols first patient in trial of renal infection therapy
23 Jun 2023 //
CLINICAL TRIALS ARENA
Memo Therapeutics AG Starts U.S. Pivotal Phase II/III Clinical Trial with AntiBK
22 Jun 2023 //
BUSINESSWIRE
Memo Announces PI Data with AntiBKV for Treatment of BKV Infection
24 Jan 2023 //
BUSINESSWIRE
Ono Enters a Drug Discovery Collaboration Agreement with Memo Therapeutics
01 Nov 2022 //
PRESS RELEASE
Memo Therapeutics initiates pioneering BK virus therapy trial
31 May 2022 //
PHARMATIMES
Memo Tx Initiates Phase 1 Clinical Study of MTX-005 Against BK Virus Infection
31 May 2022 //
BUSINESSWIRE
Memo Tx Closes Series B Financing at CHF37M Following CHF23M Extension
16 Feb 2022 //
BUSINESSWIRE
Memo Therapeutics to Receive CHF 10.5M to Develop SARS-CoV-2 Antibody
13 Dec 2021 //
BUSINESSWIRE
Memo Therapeutics AG Antibodies Against SARS-CoV-2 Show Efficacy
17 May 2021 //
BUSINESSWIRE
Memo Therapeutics AG’s Antibody Against SARS-CoV-2 Demonstrates Potent
03 Dec 2020 //
BUSINESSWIRE
Memo Therapeutics AG Raises CHF 14 Million in a Series B Financing Round
05 Nov 2020 //
BUSINESSWIRE
Memo Therapeutics Collaborates with Northway Biotechpharma
17 Aug 2020 //
CONTRACTPHARMA
Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track
14 Aug 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.